Haemonetics
HAE
$97.37
Share price
1.21%
Change (1 day)
9.21%
Change (1 year)
Categories
Market capitalization of Haemonetics (HAE)
Market cap: $4.94 Billion
As of May 2024 Haemonetics has a market cap of $4.94 Billion. This makes Haemonetics the world's 2700th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Haemonetics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $4.94 B | 13.97% |
| 2023 | $4.33 B | 9.01% |
| 2022 | $3.98 B | 46.84% |
| 2021 | $2.71 B | -55.05% |
| 2020 | $6.02 B | 4.14% |
| 2019 | $5.78 B | 13.49% |
| 2018 | $5.10 B | 66.31% |
| 2017 | $3.06 B | 47.72% |
| 2016 | $2.07 B | 26.8% |
| 2015 | $1.63 B | -15% |
| 2014 | $1.92 B | -11.86% |
| 2013 | $2.18 B | 3.66% |
| 2012 | $2.10 B | 37.9% |
| 2011 | $1.52 B | -2.18% |
| 2010 | $1.56 B | 12.84% |
| 2009 | $1.38 B | -3.57% |
| 2008 | $1.43 B | -11.01% |
| 2007 | $1.61 B | 35.76% |
| 2006 | $1.18 B | -8.49% |
| 2005 | $1.29 B | 38.66% |
| 2004 | $0.93 B | 57.6% |
| 2003 | $0.59 B | 14.35% |
| 2002 | $0.52 B | -42.09% |
| 2001 | $0.89 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Haemonetics was reported to be:
$4.94 Billion
$4.94 Billion
$4.94 Billion
$4.94 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $364.32 B | 7,267.44% | 🇺🇸 USA |
 Medtronic MDT | $111.93 B | 2,163.58% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $227.04 B | 4,491.36% | 🇺🇸 USA |
 Baxter BAX | $17.95 B | 263.14% | 🇺🇸 USA |
 Becton Dickinson BDX | $67.91 B | 1,273.42% | 🇺🇸 USA |
 Stryker Corporation SYK | $123.54 B | 2,398.30% | 🇺🇸 USA |
 PerkinElmer
PKI | $14.45 B | 192.33% | 🇺🇸 USA |
 Cerus CERS | $0.37 B | -92.37% | 🇺🇸 USA |